These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21458549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
    Pund S, Joshi A, Vasu K, Nivsarkar M, Shishoo C.
    Int J Pharm; 2010 Mar 30; 388(1-2):64-72. PubMed ID: 20035851
    [Abstract] [Full Text] [Related]

  • 3. Formulation development of gastroretentive tablets of lamivudine using the floating-bioadhesive potential of optimized polymer blends.
    Singh B, Garg B, Chaturvedi SC, Arora S, Mandsaurwale R, Kapil R, Singh B.
    J Pharm Pharmacol; 2012 May 30; 64(5):654-69. PubMed ID: 22471361
    [Abstract] [Full Text] [Related]

  • 4. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. part 6: rifampicin.
    Ammar HO, Khalil RM.
    Pharmazie; 1996 Mar 30; 51(3):165-8. PubMed ID: 8900866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P.
    Int J Pharm; 2005 Nov 04; 304(1-2):178-84. PubMed ID: 16198522
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK, Gupta P, Gupta UD, Jain NK, Agrawal GP.
    Int J Pharm; 2010 Jan 29; 385(1-2):143-9. PubMed ID: 19819315
    [Abstract] [Full Text] [Related]

  • 11. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
    Patil S, Talele GS.
    Drug Deliv; 2015 May 29; 22(3):312-9. PubMed ID: 24471787
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk based approach for design and optimization of stomach specific delivery of rifampicin.
    Vora C, Patadia R, Mittal K, Mashru R.
    Int J Pharm; 2013 Oct 15; 455(1-2):169-81. PubMed ID: 23916823
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.